Concord Biotech Limited (BOM:543960)
556.20
-4.85 (-0.86%)
At close: Nov 19, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 116.33 billion as of November 20, 2026. Its market cap has decreased by 23.24% in one year.
Market Cap
116.33B
Enterprise Value
111.85B
Revenue
11.70B
Global Rank
n/a
Country Rank
n/a
PE Ratio
41.41
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 116.33B, an increase of 17.95%. That is a compound annual growth rate of 5.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 114.70B | -18.52% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 593.35B |
| Anthem Biosciences | 534.47B |
| OneSource Specialty Pharma | 184.62B |
| Concord Biotech | 114.76B |
| Blue Jet Healthcare | 97.24B |
| Supriya Lifescience | 50.06B |
| Zota Health Care | 44.82B |
| Panacea Biotec | 20.64B |